INS and type 1 diabetes mellitus: The <0.20 nmol/mmol threshold maximizes specificity (95.0%) while maintaining high sensitivity (94.7%), making it ideal for confirming T1DM diagnosis when avoiding false positives is crucial—such as before initiating insulin pump therapy or when qualifying for T1DM-specific clinical trials.